Search results for "Venous thromboembolism"
MKSAP Quiz: Counseling regarding contraceptives
A 19-year-old woman is seen for counseling regarding contraceptives. Medical history is unremarkable; she is nulliparous and has never taken prescription contraceptives. Her father had a pulmonary embolism at age 47 years, which was associated with arthroscopic knee surgery, and her 23-year-old sister experienced a deep venous thrombosis 3 weeks after delivering her first child. The patient does not smoke and takes no medications. Which contraceptive method would be most appropriate for this patient?
https://immattersacp.org/weekly/archives/2018/01/23/3.htm
23 Jan 2018
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021
Aspirin didn't reduce recurrent VTE but did reduce major vascular events
Low-dose aspirin may have therapeutic benefit for patients who have completed initial anticoagulant therapy for an unprovoked venous thromboembolism (VTE) even though the rate of recurrent VTE was not significantly reduced in a recent study.
https://immattersacp.org/weekly/archives/2012/11/13/1.htm
13 Nov 2012
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a new trial, tocilizumab had mixed results, and remdesivir got full approval, among other COVID-19 news.
https://immattersacp.org/weekly/archives/2020/10/27/1.htm
27 Oct 2020
Wells score, negative D-dimer test can rule out pulmonary embolism in primary care
A Wells score of 4 or lower and a negative qualitative D-dimer test result can safely and efficiently exclude pulmonary embolism in primary care, a study found.
https://immattersacp.org/weekly/archives/2012/10/16/5.htm
16 Oct 2012
IDSA issues new clinical practice guideline for outpatient parenteral antimicrobial therapy
The new guideline updates 2004 recommendations from the Infectious Diseases Society of America (IDSA) with evidence from recent research, particularly on the safety of outpatient parenteral therapy.
https://immattersacp.org/weekly/archives/2018/11/20/5.htm
20 Nov 2018
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020
Web-based decision support tool may help determine safety of outpatient PE management
The tool was added to the patient care workflow in the ED after the diagnosis of pulmonary embolism (PE) was confirmed but before site-of-care decision making was completed.
https://immattersacp.org/weekly/archives/2018/11/13/4.htm
13 Nov 2018
Use of hormonal contraceptive pills may be associated with increased risk of breast cancer
While the 20% increased risk among women using contemporary formulations of oral contraceptives is similar to that initially reported among users of older formulations, an editorial noted, the finding that breast cancer risk continues to be elevated for five years or more should be regarded as preliminary because the increase in risk would not have remained significant after adjustment.
https://immattersacp.org/weekly/archives/2017/12/12/4.htm
12 Dec 2017
Fixed-dose oral rivaroxaban appears noninferior to standard therapy for PE
Fixed-dose oral rivaroxaban is as effective as standard anticoagulant therapy for pulmonary embolism (PE) and may have a lower bleeding risk, a new study found.
https://immattersacp.org/weekly/archives/2012/03/27/5.htm
27 Mar 2012